These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36279734)

  • 1. Acid liberalism: Silicon Valley's enlightened technocrats, and the legalization of psychedelics.
    Tvorun-Dunn M
    Int J Drug Policy; 2022 Dec; 110():103890. PubMed ID: 36279734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historicizing psychedelics: counterculture, renaissance, and the neoliberal matrix.
    Sanchez Petrement M
    Front Sociol; 2023; 8():1114523. PubMed ID: 37808425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency.
    Pace BA; Devenot N
    Front Psychol; 2021; 12():733185. PubMed ID: 34975622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics.
    Kruger DJ; Barron J; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(5):650-659. PubMed ID: 37353935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics.
    Langlitz N; Dyck E; Scheidegger M; Repantis D
    Front Psychiatry; 2021; 12():680064. PubMed ID: 34408677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens.
    Dupuis D
    Front Psychol; 2021; 12():730031. PubMed ID: 34887799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying.
    Mackenzie R
    Curr Drug Abuse Rev; 2014; 7(3):136-45. PubMed ID: 25563449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity.
    Hartogsohn I
    Front Neurosci; 2018; 12():129. PubMed ID: 29559884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics and neonihilism: connectedness in a meaningless world.
    Plesa P; Petranker R
    Front Psychol; 2023; 14():1125780. PubMed ID: 37621941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do psychedelics change beliefs?
    McGovern HT; Leptourgos P; Hutchinson BT; Corlett PR
    Psychopharmacology (Berl); 2022 Jun; 239(6):1809-1821. PubMed ID: 35507071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing.
    Qiu TT; Minda JP
    J Psychoactive Drugs; 2023; 55(2):123-133. PubMed ID: 35438609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture.
    Hartogsohn I
    Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction specialists' attitudes toward psychedelics: A National Survey.
    Kim A; Suzuki J
    Am J Addict; 2023 Nov; 32(6):606-609. PubMed ID: 37550848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B; Luoma JB; Bathje GJ; Rhea J; Narloch VF
    Harm Reduct J; 2021 Apr; 18(1):40. PubMed ID: 33827588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing.
    Jylkkä J; Krabbe A; Jern P
    Sci Rep; 2024 Jun; 14(1):13276. PubMed ID: 38858435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
    Kangaslampi S; Hausen A; Rauteenmaa T
    J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.